ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
10.877
0.00
(0.00%)
At close: September 20 4:00PM
10.877
0.00
( 0.00% )

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
10.877
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
10.877
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,317,000
Dividend Yield
-
PE Ratio
177.08
Earnings Per Share (EPS)
0.05
Revenue
163k
Net Profit
281k

About Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Show more

Sector
Surgical,med Instr,apparatus
Industry
Misc Health & Allied Svc,nec
Website
Headquarters
Oak Ridge, New Jersey, USA
Founded
2010

DXR Latest News

Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors

Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers...

Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022

Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The...

Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh...

DAXOR ANNOUNCES KEY MILESTONES ACHIEVED FOR MULTICENTER BVA-100® STUDY IN HOSPITALIZED PATIENTS WITH COVID-19

Patient Enrollment Complete and Data Analysis Commences with Daxor’s Blood Volume Analysis Technology Oak Ridge, TN, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the...

DAXOR AWARDED NEW PATENT FOR BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES

Method Patent Covers Blood Volume Analysis Technology to Evaluate and Guide Treatment Decisions in Multiple Medical Conditions Oak Ridge, TN, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation...

Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting

Two New Studies Presented at the American Heart Association Scientific Sessions 2021, Adoption of Technology Reported as “Excellent” and “Valuable” by Lead Authors Oak Ridge, TN, Nov. 16, 2021...

New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical Care

Data Presented at the NeuroCritical Care Society 19th Annual Meeting 2021 Data Highlight Daxor’s Diagnostic Changes Care in 69% of Patients With Non-Traumatic Subarachnoid Hemorrhage (nSAH) NEW...

Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee

The SBIR/STTR Matching Fund Grant Will Advance the Company’s Innovation and Commercialization Efforts, and Job Creation Oak Ridge, TN, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE:...

Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at Key Scientific Society Meeting

Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing...

Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021

Oak Ridge, TN, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PMNTPerfect Moment Ltd
$ 1.2731
(15.61%)
794
FRDFriedman Industries Inc
$ 16.2299
(7.98%)
4.69k
SGNSigning Day Sports Inc
$ 0.28
(7.69%)
537.71k
SOARVolato Group Inc
$ 0.3939
(7.68%)
2.82k
ENSVENSERVCO Corporation
$ 0.112
(7.49%)
49.92k
PZGParamount Gold and Silver Corp
$ 0.45
(-11.76%)
229.83k
AIMAIM ImmunoTech Inc
$ 0.24
(-10.18%)
118.57k
INUVInuvo Inc
$ 0.2483
(-8.71%)
53.11k
RCGRENN Fund Inc
$ 1.89
(-8.25%)
1.33k
IBIOiBio Inc
$ 1.85
(-6.09%)
8.54k
SPYSPDR S&P 500
$ 568.25
(0.02%)
15.26M
SVMSilvercorp Metals Inc
$ 4.2197
(-0.71%)
13.66M
XLFFinancial Select Sector
$ 45.61
(-0.11%)
10.21M
GSATGlobalstar Inc
$ 1.24
(0.81%)
8.72M
IAUXi 80 Gold Corp
$ 1.10
(0.00%)
8.72M

DXR Discussion

View Posts
r clarke r clarke 2 years ago
Spiked to $9.72 for a couple of trades.
Anyone still following DXR?
👍️0
r clarke r clarke 2 years ago
Spiked to $9.72 for a couple of trades.
Anyone still following DXR?
👍️0
eom7 eom7 4 years ago
Watching now!
👍️0
axconth axconth 4 years ago
Up 3% today. Was told their analyzer
sales might get a boost due to COVID19?
Anyone following this, how is it a COVID play?
👍️0
crudeoil24 crudeoil24 4 years ago
Daxor’s FDA-cleared diagnostic instrument used in critical care can help guide treatment, as the BVA-100 measures patients’ blood, plasma and red cell volume and calculates the ideal blood volume that the patient should have, with statistics showing deviations from the patient-specific ideal. The BVA is the only test that provides a unique measure of capillary permeability via its albumin tracer, an important insight into COVID-19 pathophysiology. This study aims to show the implications of COVID as an endothelial disease utilizing this measure.
👍️0
whytestocks whytestocks 4 years ago
News: $DXR Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company's Board of Directors

NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointments of Dr. Henry D. Cremisi and Joy Goudie, Esq. to the...

Got this from DXR - Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company's Board of Directors
👍️0
crudeoil24 crudeoil24 5 years ago
SUPER LOW FLOAT >
👍️0
TheFinalCD TheFinalCD 5 years ago
15-16-17 that quick!!



DXR
👍️0
whytestocks whytestocks 5 years ago
News: $DXR Daxor Corporation to Present at the LD Micro 9th Annual Invitational on June 4th, 2019

NEW YORK, May 31, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces that Michael Feldschuh, chief executive officer of Daxor Corporat...

Got this from https://marketwirenews.com/news-releases/daxor-corporation-to-present-at-the-ld-micro-9th-annual-invitational-on-june-4th-2019-8276920.html
👍️0
whytestocks whytestocks 5 years ago
News: $DXR Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice

NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces a new partnership with a leading hospital in North Carolina to in...

Read the whole news https://marketwirenews.com/news-releases/daxor-corporation-announces-new-partnership-with-leading-hospital-in-north-carolina-to-integrate-the-bva-100-xae-blood-volume-analyzer-diagnostic-test-as-part-of-standard-clinical-practice-8269202.html
👍️0
jfk jfk 5 years ago
$7.67...<$7 soon? We will be seeing some very low numbers here....
👍️0
jfk jfk 5 years ago
Nothing to keep this at this level unless they put out some news. Could easily drop <$7 with zero communication. Need some customer engagements....trials....anything!!
👍️0
Glider549 Glider549 6 years ago
I hate Seeking Alpha.
They can spew any lies they like without a retraction.
👍️0
stocktrademan stocktrademan 6 years ago
DXR buy 11.85



https://www.daxor.com/



normal chart







log chart






👍️0
Glider549 Glider549 6 years ago
Looks like yesterday's presentation did not go well,, grrrrr!
👍️0
Glider549 Glider549 6 years ago
That last hour and a half of the trading day was weird.
Glad it ended up in the green.
👍️0
Glider549 Glider549 6 years ago
That was a nice close Gaffster.
👍️0
dirtydozen911 dirtydozen911 6 years ago
up 15% on a sh**ty day!....this has been moving up slow and steady for a month now......sales for the bva100 must be good !!

expecting a good Q....this should take off....glta
👍️0
weekendwarrior1 weekendwarrior1 6 years ago
Alright let’s see what this can do today!
👍️0
BoilerRoom BoilerRoom 6 years ago
Ugggggh no wonder this crashed another Jason Bond play. Folks he’s the worst stock promoter out there. Here is his latest alert:

JasonBondPicks: DXR didn't want it, took my loss at 7.11 -3600. will rebuy later today or tomorrow for friday f/r
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Agreed!!!!!
👍️0
BoilerRoom BoilerRoom 6 years ago
$DXR $9.50 today
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Yep...with all the momentum from Yesterday in the high $8.00's this should have a good day.
👍️0
TheFinalCD TheFinalCD 6 years ago
$7.75 +.50 FROM BOTTOM
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Let's make this money!!!
👍️0
BoilerRoom BoilerRoom 6 years ago
$DXR took starter low $7.00 let’s go!
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
I'm buying!!!!
👍️0
cjstocksup cjstocksup 6 years ago
I see that, watching to see if I want to add or sell the last of my shares. Not sure yet.
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
This is only premarket.
👍️0
TheFinalCD TheFinalCD 6 years ago
DXR $7.25

👍️0
BoilerRoom BoilerRoom 6 years ago
$DXR
👍️0
TheFinalCD TheFinalCD 6 years ago
still holding 9 shares that didnt fill, considering rebuying $8-$8.10


Open: Part. Filled Sell
9
DXR Limit
8.99
--
02

28

19
--


Filled Sell 434 DXR Limit 8.99 -- -- 16:05:39 10/30/18


Filled Sell 500 DXR Limit 8.99 -- -- 16:05:52 10/30/18


Filled Sell 2 DXR Limit 8.99 -- -- 16:06:15 10/30/18


Filled Sell 25 DXR Limit 8.99 -- -- 16:05:39 10/30/18


Filled Sell 30 DXR Limit 8.99 -- -- 16:06:23 10/30/18
👍️0
s366sxe s366sxe 6 years ago
Gap down, I’m starting to sweat
👍️0
ClayTrader ClayTrader 6 years ago
* * $DXR Video Chart 10-30-18 * *

Link to Video - click here to watch the technical chart video

👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Agreed. Just like last time.
👍️0
Biggeoff Biggeoff 6 years ago
No offering as expected. Will hit $15 tomorrow easily
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Right!!! Bigger tommorrow.
👍️0
cjstocksup cjstocksup 6 years ago
DXR easy flips so far today but the rest I am holding long. Tomorrow should be much bigger. Plus I will have more cash now in case of any dips ahead. GL
👍️0
TheFinalCD TheFinalCD 6 years ago
Thanks I made 4-5 trades so far


ALL GREEN
👍️0
cjstocksup cjstocksup 6 years ago
DXR awesome day! Congrats to all who made $$$.
👍️0
TheFinalCD TheFinalCD 6 years ago
8.20 to 7.74 in seconds

👍️0
peterus peterus 6 years ago
maby run ah ?
👍️0
peterus peterus 6 years ago
game over
👍️0
TheFinalCD TheFinalCD 6 years ago
I missed that move 7.04-7.79 (+.75/share)


and would have got filled if I didnt cancel



Canceled Buy 500 DXR Limit 7.16 -- 10/30/18 12:52:37 10/30/18



Canceled Buy 500 DXR Limit 7.14 -- 10/30/18 11:59:36 10/30/18



Canceled Buy 500 DXR Limit 7.11 -- 10/30/18 12:24:11 10/30/18
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Amazing News. This is only the beginning guys.
👍️0
wickerman wickerman 6 years ago
DXR great news and love the low float too
👍️0
TheFinalCD TheFinalCD 6 years ago
I made my trades... all green trades so far


just missed getting filled on this dip

I was bidding 7.70

it came down to 7.72

thats what I get for being cheap

I should have been @ 7.73

👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Wow.....$10+ soon
👍️0
$avvyPenny$tockInvestor™ $avvyPenny$tockInvestor™ 6 years ago
Im in bro. Wow
👍️0
TheFinalCD TheFinalCD 6 years ago
bought more DXR 8.54 just hit 9.20's
👍️0

Your Recent History

Delayed Upgrade Clock